Articles published by OKYO Pharma LTD





OKYO Pharma Announces Closing of $4.0 Million Registered Direct Offering of Ordinary Shares
September 15, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO

OKYO Pharma Announces Pricing of $4.0 Million Registered Direct Offering of Ordinary Shares
September 14, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO

OKYO Pharma Limited Announces Withdrawal of Public Offering
September 14, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO

OKYO Pharma Announces Public Offering of Ordinary Shares
September 13, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO

OKYO Pharma Completes Enrollment in Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease
September 08, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO


OKYO Pharma Limited Regains Compliance with Nasdaq Listing Minimum Market Value Rule
August 29, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO

OKYO Pharma Limited Reports Annual Results for the Twelve Months Ended March 31, 2023
August 15, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO



OKYO Pharma Limited Receives Nasdaq Deficiency Notice
July 28, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO








Notice of General Meeting and Publication of Circular
April 05, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO

Notice of Intention to Delist From The London Stock Exchange
April 04, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO

OKYO Pharma Today Announces Director Acquires Shares
March 30, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO

OKYO Pharma Today Announces Director Acquires Shares
March 29, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO

OKYO Pharma Announces PDMR Dealing
March 24, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO



OKYO Pharma Limited Prices $5.3 Million Offering of ADSs
March 13, 2023
From OKYO Pharma LTD
Via GlobeNewswire
Tickers
OKYO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.